← FDA Drug Approvals (Drugs@FDA)
TAZAROTENE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2023-04-25
Drug application
- FDA Application #
ANDA213079- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TAZAROTENE
- Generic name
- TAZAROTENE
- Active ingredients
- TAZAROTENE
- Dosage form
- GEL
- Route
- TOPICAL
- Marketing status
- Prescription
- Sponsor
- PADAGIS ISRAEL
- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- First approval
- 2023-04-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown